Study challenges long-standing concept in cancer metabolism

October 5, 2017
Dr. Ralph DeBerardinis. Credit: UT Southwestern

Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered that lactate provides a fuel for growing tumors, challenging a nearly century-old observation known as the Warburg effect.

This new finding may represent a major shift in how researchers view metabolism and open a new avenue of study for therapies and imaging techniques for , which is the leading cause of carcinoma deaths worldwide.

"We were completely shocked by our findings," said Dr. Ralph DeBerardinis, Professor at CRI, Director of CRI's Genetic and Metabolic Disease Program, and Chief of the Division of Pediatric Genetics and Metabolism at UT Southwestern. "The oldest observation in , the Warburg effect, says that lactate is a waste product of the tumor. This concept has driven the vast amount of research in the field. Our finding is a fundamental change in how we think about tumor metabolism."

The Warburg effect, named after the German cancer biologist Otto Warburg, has three main components:

  • Rapid glucose uptake.
  • Reduced glucose oxidation even when oxygen is present.
  • Secretion of lactate as a waste product.

In the study published in Cell, CRI researchers showed lactate is not only a but also acts as a fuel source consumed by lung cancer cells growing in patients and mice. Combined with a previous study, also published in Cell, from the DeBerardinis lab that showed activated in tumors, the results of this study are challenging the tenets of the Warburg effect.

"We believe that lactate is one of the fuels that supports growth, proliferation, and maybe even lung cancer metastases," Dr. DeBerardinis said. "Cancer metabolism is clinically actionable, and understanding the lactate pathway could help us find therapeutic targets for lung cancer. Lactate uptake could also have predictive value when used as an imaging tracer."

Additional findings in the study suggest a potential link between lactate use and cancer aggression.

"The findings are preliminary, but we did see a connection between lactate utilization and how quickly the tumors metastasized or recurred. This result suggests that there is something fundamental about the utilization pathway that pertains to the clinical aggressiveness of the ," said Dr. Brandon Faubert, a Canadian Institutes of Health Research Fellow at CRI and lead author of the study.

An important factor in these new discoveries was the collaboration between scientists at CRI and the clinical team at UT Southwestern. Working closely with medical personnel in Radiology, Pathology, Pharmacy, Anesthesiology, and the surgical team, researchers were able to analyze the of tumors during surgeries performed to remove the tumors. This approach provided researchers with vital insights that would not occur in laboratory-based experiments.

Explore further: Natural molecule appears to shut off cancer cells' energy source

More information: Lactate Metabolism in Human Lung Tumors, Cell (2017). dx.doi.org/10.1016/j.cell.2017.09.019 , www.cell.com/cell/fulltext/S0092-8674(17)31068-1

Christopher T. Hensley et al. Metabolic Heterogeneity in Human Lung Tumors, Cell (2016). DOI: 10.1016/j.cell.2015.12.034

Related Stories

Natural molecule appears to shut off cancer cells' energy source

September 14, 2017
The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy—something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth.

Does lactate, the bane of athletes, help drive cancer?

March 15, 2017
For decades, lactate has been studied largely in the context of exercise, painted as a nagging metabolic byproduct that accumulates in the tissues and blood during workouts, stiffening muscles and hindering performance.

PGK1 protein promotes brain tumor formation and cancer metabolism

March 3, 2016
PGK1, a glycolytic enzyme, has been found to play a role in coordinating cellular processes crucial to cancer metabolism and brain tumor formation, according to results published in today's online issue of Molecular Cell. ...

Lactate metabolism target halts growth in lung cancer model

April 10, 2014
Cancer cells generate energy differently than normal cells, a characteristic that helps them to survive and metastasize. A major goal in the field of cancer metabolism is to find ways to overcome this survival advantage.

Scientists surprised to find that amino acids, not sugar, supply most building blocks for tumor cells

March 7, 2016
Cancer cells are notorious for their ability to divide uncontrollably and generate hordes of new tumor cells. Most of the fuel consumed by these rapidly proliferating cells is glucose, a type of sugar.

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.